Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers
Dufva Olli; Gandolfi Sara; Huuhtanen Jani; Dashevsky Olga; Duàn Hanna; Saeed Khalid; Klievink Jay; Nygren Petra; Bouhlal Jonas; Lahtela Jenni; Näätänen Anna; Ghimire Bishwa R.; Hannunen Tiina; Ellonen Pekka; Lähteenmäki Hanna; Rumm Pauliina; Theodoropoulos Jason; Laajala Essi; Härkönen Jouni; Pölönen Petri; Heinäniemi Merja; Hollmén Maija; Yamano Shizuka; Shirasaki Ryosuke; Barbie David A.; Roth Jennifer A.; Romee Rizwan; Sheffer Michal; Lähdesmäki Harri; Lee Dean A.; De Matos Simoes Ricardo; Kankainen Matti; Mitsiades Constantine S.; Mustjoki Satu
https://urn.fi/URN:NBN:fi-fe2025082791621
Tiivistelmä
Cancer cells can evade natural killer (NK) cell activity, thereby limiting anti-tumor immunity. To reveal genetic determinants of susceptibility to NK cell activity, we examined interacting NK cells and blood cancer cells using single-cell and genome-scale functional genomics screens. Interaction of NK and cancer cells induced distinct activation and type I interferon (IFN) states in both cell types depending on the cancer cell lineage and molecular phenotype, ranging from more sensitive myeloid to less sensitive B-lymphoid cancers. CRISPR screens in cancer cells uncovered genes regulating sensitivity and resistance to NK cell-mediated killing, including adhesion-related glycoproteins, protein fucosylation genes, and transcriptional regulators, in addition to confirming the importance of antigen presentation and death receptor signaling pathways. CRISPR screens with a single-cell transcriptomic readout provided insight into underlying mechanisms, including regulation of IFN-γ signaling in cancer cells and NK cell activation states. Our findings highlight the diversity of mechanisms influencing NK cell susceptibility across different cancers and provide a resource for NK cell-based therapies.
Kokoelmat
- Rinnakkaistallenteet [29337]
